From: Sex-specific associations of kynurenic acid with neopterin in Alzheimer’s disease
Trp | Kyn | KA | AA | 3-HK | Pic | QA | KA/QA | |
---|---|---|---|---|---|---|---|---|
A. Whole cohort | ||||||||
Diagnoses | -0.09 | 0.12 | 0.28* | -0.23* | 0.05 | 0.22* | 0.01 | 0.30* |
Age | 0.06 | 0.15* | 0.17* | 0.17* | 0.11 | -0.02 | 0.32* | 0.08 |
Sex | 0.18* | 0.15* | 0.03 | -0.10 | 0.09 | 0.24* | 0.19* | -0.02 |
APOE ɛ4 genotype | 0.01 | -0.09 | -0.03 | 0.04 | 0.04 | -0.01 | 0.00 | -0.02 |
Amyloid-β42 | -0.02 | 0.02 | -0.06 | 0.08 | 0.01 | -0.06 | 0.00 | -0.06 |
P-tau181 | -0.02 | -0.10 | 0.17* | -0.05 | -0.03 | 0.07 | -0.05 | 0.20* |
Neopterin (log10) | 0.07 | 0.47* | 0.39* | 0.08 | 0.20* | 0.05 | 0.40* | 0.30* |
Neopterin x sex | 0.09 | 0.00 | -0.16 | -0.05 | -0.01 | 0.05 | 0.01 | -0.19* |
Adjusted R2 | 0.07 | 0.29 | 0.20 | 0.08 | 0.05 | 0.07 | 0.39 | 0.14 |
B. AD | ||||||||
Age | 0.02 | 0.08 | 0.12 | 0.12 | 0.14 | -0.03 | 0.30* | 0.03 |
Sex | 0.16* | 0.14* | 0.01 | -0.13 | 0.05 | 0.27* | 0.20* | -0.06 |
Amyloid-β42 | 0.09 | -0.03 | 0.00 | -0.13 | 0.00 | -0.03 | 0.00 | -0.01 |
P-tau181 | 0.04 | -0.13 | 0.20* | -0.15 | -0.05 | 0.03 | -0.07 | 0.24* |
Neopterin (log10) | 0.09 | 0.50* | 0.48* | 0.16 | 0.23* | 0.02 | 0.44* | 0.37* |
Neopterin x sex | 0.00 | -0.05 | -0.22* | -0.04 | -0.05 | 0.07 | -0.07 | -0.23* |
Adjusted R2 | 0.03 | 0.26 | 0.24 | 0.06 | 0.05 | 0.06 | 0.36 | 0.15 |
C. CU | ||||||||
Age | 0.22 | 0.25* | 0.31* | 0.21 | -0.08 | 0.00 | 0.29* | 0.22 |
Sex | 0.11 | -0.16 | 0.12 | -0.15 | 0.15 | 0.14 | 0.14 | 0.11 |
Amyloid-β42 | 0.04 | -0.04 | 0.20 | 0.00 | 0.02 | 0.09 | -0.01 | 0.21 |
P-tau181 | -0.24* | -0.17 | 0.08 | -0.11 | -0.02 | -0.01 | 0.00 | 0.09 |
Neopterin (log10) | 0.00 | 0.34 | 0.16 | -0.15 | 0.21 | 0.09 | 0.24 | 0.13 |
Neopterin x sex | 0.31 | 0.10 | -0.13 | 0.09 | 0.20 | 0.02 | 0.22 | -0.23 |
Adjusted R2 | 0.21 | 0.31 | 0.13 | -0.01 | 0.10 | -0.02 | 0.37 | 0.06 |